AI Pick

  • Peugeot’s All-New 5008 Smart Hybrid Targets South Korea’s Family SUV Market
    Peugeot’s All-New 5008 Smart Hybrid Targets South Korea’s Family SUV Market As SUVs continue to dominate South Korea’s auto market, Peugeot is seeking to expand sales with the “All-New 5008 Smart Hybrid,” a full redesign returning after 10 years. Planned and built in France, the third-generation 5008 combines Stellantis’ next-generation STLA electrified platform with a smart-hybrid powertrain. It is a family SUV that can seat up to seven. On Feb. 2 in Gimpo, the new 5008’s front end showcased Peugeot’s latest family design, including a floating-style emblem, a February 4, 2026
  • Hanmi Pharmaceutical ramps up R&D push with homegrown drugs and global expansion plans
    Hanmi Pharmaceutical ramps up R&D push with homegrown drugs and global expansion plans Hanmi Pharmaceutical said it has held the top spot in South Korea’s outpatient prescription sales for seven straight years, driven by drugs developed with its own technology. The company said more than 90% of its revenue comes from in-house products, and it is accelerating efforts to find new global growth engines through research and development. Industry officials said Hanmi’s R&D spending as a share of revenue rose from 13.4% in 2022 to 15.2% as of the third quarter of last year. February 3, 2026
  • Hanwha Aerospace Launches $22 Million Supplier Innovation Profit-Sharing Program
    Hanwha Aerospace Launches $22 Million Supplier Innovation Profit-Sharing Program Hanwha Aerospace said it will launch a supplier innovation profit-sharing program aimed at advancing cutting-edge defense technology and supporting shared growth by directing its defense R&D funding to suppliers’ research and expanded intellectual property. The company held a ceremony on Monday at its R&D center at its Plant 3 site in Changwon, South Korea, with about 80 attendees, including representatives from 56 suppliers as well as central and local government officials. Hanwha Aero February 3, 2026
  • Mizuno Korea Launches JPX ONE Driver With First-Ever Nanoalloy Face
    Mizuno Korea Launches JPX ONE Driver With First-Ever Nanoalloy Face Mizuno Korea said Monday it has released the 2026 JPX ONE driver, the first driver to use a “nanoalloy face.” The JPX ONE driver is a new lineup aimed at delivering faster ball speed, high forgiveness and Mizuno’s distinctive impact feel. The “ONE” name replaces the previous JPX 923 and 925 naming, and is intended to signal a new start and an aim for No. 1, the company said. At the center of the club is the NANOALLOY™ FACE, which Mizuno Korea said is the first time the technology ha February 3, 2026
  • SK Bioscience Sales Jump 143% on Strong Results From German Unit IDT
    SK Bioscience Sales Jump 143% on Strong Results From German Unit IDT SK Bioscience said strong results from its German subsidiary, acquired two years ago, helped more than double its annual revenue last year. In a regulatory filing on Monday, the company said 2025 revenue on a consolidated basis rose 143.5% from a year earlier to 651.4 billion won. Its operating loss narrowed to 123.5 billion won from 138.4 billion won in 2024. The improvement was driven largely by IDT, a Germany-based contract development and manufacturing organization acquired in 2024. February 3, 2026
  • Celltrion, SK Chemicals, HLB Pharma and Myung In Pharma report Europe share, sales deal, revenue and governance moves
    Celltrion, SK Chemicals, HLB Pharma and Myung In Pharma report Europe share, sales deal, revenue and governance moves Celltrion: Remsima autoimmune drugs held 68% share in Europe last year Celltrion said Monday that its treatments for autoimmune diseases and cancer continue to hold strong market share in Europe. Citing IQVIA, the company said its Remsima product family for autoimmune diseases (IV and SC) posted a combined market share of about 68% in Europe as of the third quarter of last year. Both the intravenous and subcutaneous formulations showed steady prescribing trends. Shares were 81% in Franc February 3, 2026
  • Canada’s defense procurement minister visits Hanwha Aerospace plant, cites potential for deeper cooperation
    Canada’s defense procurement minister visits Hanwha Aerospace plant, cites potential for deeper cooperation Canadian Minister of State for Defense Procurement Stephen Fuhr visited Hanwha Aerospace’s Changwon site, a day after touring facilities run by Hanwha Ocean and Hyundai Rotem to review major South Korean defense systems. Hanwha Aerospace said Fuhr, a delegation of Canadian company representatives and others — about 30 people — visited its Plants 2 and 3 in Changwon, South Gyeongsang province, on Feb. 3. The group toured production lines for the K9 self-propelled howitzer, the K10 ammuniti February 3, 2026
  • Asiana Airlines posts 342.5 billion won operating loss in 2025, first annual loss in five years
    Asiana Airlines posts 342.5 billion won operating loss in 2025, first annual loss in five years Asiana Airlines said in a regulatory filing on Monday that it posted standalone revenue of 6.1969 trillion won last year and an operating loss of 342.5 billion won. Revenue fell 12.2% from a year earlier, and the company swung to an operating loss. It was Asiana’s first annual loss in five years, since 2020, when it reported a 63.1 billion won loss amid the COVID-19 pandemic. Passenger revenue fell by 76.8 billion won to 4.5696 trillion won. Asiana said tighter U.S. entry restrictions w February 3, 2026
  • KCC’s Heo Ung Hits 14 3-Pointers in One Game, Surpassing Stephen Curry’s Mark
    KCC’s Heo Ung Hits 14 3-Pointers in One Game, Surpassing Stephen Curry’s Mark This series takes a closer look at players and the issues around them, using interviews, records and career context. <Editor’s note> Busan KCC guard Heo Ung topped a single-game 3-point record associated with Stephen Curry, the NBA’s best-known long-range shooter. Heo made 14 3-pointers on Monday against Seoul SK at Jamsil Students Gymnasium, leading KCC to a 120-77 road win in the fifth round of the 2025-2026 LG Electronics Pro Basketball season. He finished 16 of 26 f February 3, 2026
  • Genesis AI Healthcare VP Kang Si Cheol Named AI Technology Adviser to Seoul Medical Center
    Genesis AI Healthcare VP Kang Si Cheol Named AI Technology Adviser to Seoul Medical Center Genesis AI Healthcare said Tuesday that its vice chairman, Kang Si Cheol, was appointed an artificial intelligence technology adviser to Seoul Medical Center on Monday. The company said the move is aimed at accelerating AI-driven medical innovation and helping the public hospital lead digital transformation. Kang, an AI medicine scholar and practitioner, has written books spanning theory and practice, including "AI Big History: 10 Wins Out of 22," "Artificial Intelligence Networks and Sup February 3, 2026